High-performance liquid chromatographic determination of Seratrodast (cas 112665-43-7) and its metabolites in human serum and urine
-
Add time:07/23/2019 Source:sciencedirect.com
A high-performance liquid chromatographic (HPLC) method was developed for the simultaneous determination of Seratrodast (cas 112665-43-7), a new antiasthmatic drug, and its metabolites (M-I to M-III) in human serum and urine. The method for serum and urine with and without enzymatic hydrolysis using β-glucuronidase involved liquid–liquid extraction and chemical oxidation with iron(III) chloride. The compounds in the extract were analyzed using HPLC with UV detection at 266 nm. The detection limits of seratrodast, M-I, M-II and M-III in serum and urine were 5–10 and 5–20 ng/ml, respectively, and those of deconjugated compounds in urine were 10–50 ng/ml. The method was applicable for human serum and urine from clinical trials.
We also recommend Trading Suppliers and Manufacturers of Seratrodast (cas 112665-43-7). Pls Click Website Link as below: cas 112665-43-7 suppliers
Prev:Structure–activity relationships of natural and non-natural amino acid-based amide and 2-oxoamide inhibitors of human phospholipase A2 enzymes
Next:Isolation and structure elucidation of the major photodegradation products of Seratrodast (cas 112665-43-7)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Antagonism of the TXA2 receptor by Seratrodast (cas 112665-43-7) : A structural approach07/26/2019
- A kinetic and thermodynamic study of Seratrodast (cas 112665-43-7) polymorphic transition by isothermal microcalorimetry07/25/2019
- Isolation and structure elucidation of the major photodegradation products of Seratrodast (cas 112665-43-7)07/24/2019